Upper gastrointestinal disease in elderly patients

Reviews in Clinical Gerontology

Volumn 10, Issue 3, 2000, Pages 223-233

  Singhal, S ^a   Bowling, T E ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

AGING; CANCER DIAGNOSIS; CLINICAL TRIAL; DIGESTIVE SYSTEM HEMORRHAGE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG STABILITY; DYSPHAGIA; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL CARCINOMA; GERIATRIC CARE; HUMAN; MEDICAL DECISION MAKING; PEPTIC ULCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PORTOSYSTEMIC ANASTOMOSIS; QUALITY OF LIFE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; UPPER GASTROINTESTINAL TRACT; VARICOSIS;

EID: 0033657719     PISSN: 09592598     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0959259800010339     Document Type: Review

References (96)

1. Disorders of the upper gastrointestinal tract
2. The ageing oesophagus
3. Oesophageal disease in the elderly
4. Cineradiographic evaluation of the oesophagus in normal adults. A study of 146 subjects ranging in age from 21 to 90 years
5. Oesophageal motility in the elderly
6. Oesophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of abnormal contractors
7. The influence of ageing on oesophageal motility after ingestion of liquids with different viscosities
8. Long-term oesophageal manometry in healthy subjects. Evaluation of normal values and influence of age
9. Clinical spectrum of oesophageal aperistalsis in the elderly
10. Content of family practice. Part I. Rank order of diagnosis by frequency. Part II. Diagnosis by disease category and age/sex distribution
11. Oesophageal pH monitoring
12. Correlation between manometric and pH tests for gastrooesophageal reflux
13. Oesophageal mucosal diseases in the elderly
14. Achalasia or malignancy? Confirmation of the diagnosis by oesophageal manometry
15. Achalasia of the oesophagus in elderly patients responds poorly to conservative therapy
16. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaoesophagus or epiphrenic diverticulum
17. Clinical oesophageal pH recording: A technical review for practice guideline development
18. Management of patients with giant paraoesophageal hernia
19. Initial experience with laparoscopic fundoplication in the Netherlands and comparison with an established technique (Belsey Mark IV)
20. Laparoscopic Nissen fundoplication is an effective treatment for gastrooesophageal reflux disease
21. Laparoscopic fundoplication for gastrooesophageal reflux
22. Laparoscopic Nissen fundoplication
23. Oesophageal motility and outcomes following laparoscopic paraoesophageal hernia repair and fundoplication
24. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis
25. Incidence of and mortality from acute upper gastrintestinal haemorrhage in the United Kingdom
26. Diagnostic yield of upper gastrintestinal endoscopy in relation to age: Retrospective analysis of 8043 patients
27. Effect of ageing on gastric and duodenal mucosal prostaglandin concentrations in humans
28. Effects of age on gastric alkaline and nonparietal fluid secretion in humans
29. Age-related changes in gastric blood flow in rats
30. Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy
31. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation
32. Atrophic gastritis in the aged
33. Treatment of Helicobacter pylori infection
34. Helicobacter pylori and peptic ulceration: Histopathological aspects
35. Randomized double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection
36. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
37. Effect of ranitidine on gastroduodenal mucosal damage induced by non-steroidal anti-inflammatory drugs
38. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy
39. Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study
40. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
41. A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis
42. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis
43. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
44. Cimetidine therapy in non-steroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation
45. Sucralfate treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage
46. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
47. Changing clinical pattern of gastric ulcer: Are anti-inflammatory drugs involved?
48. Clinical pharmacokinetics of nimesulide
49. When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations
50. The cyclooxygenase-2 inhibitors: Safety and effectiveness
51. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?
52. COX-2: Separating myth from reality
53. Value of centralised approach in the management of haematemesis and melaena: Experience in a district general hospital
54. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: A case-control study
55. Selective outpatient management of upper gastrointestinal bleeding in the elderly
56. The prognosis of elderly subjects with oesophageal varices
57. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of oesophageal varices
58. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propanolol for prevention of variceal rebleeding
59. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial
60. Resectional surgery in carcinoma of the oesophagus and cardia: What influences long-term survival?
61. Oesophagogastrectomy in the elderly high-risk patients: Role of effective regional analgesia and early mobilisation
62. Cancer of the oesophagus and cardia: Does age influence treatment selection and surgical outcomes?
63. Multimodal treatment of oesophageal carcinoma
64. Survival and prognostic factors in patients with resected epidermoid oesophageal carcinoma
65. Pathological characteristics of gastric carcinomas in the very old
66. Early detection and treatment of oesophageal and gastric cancer
67. Evaluation of surgical treatment for patients with gastric cancer who are over 80 years of age
68. Total gastrectomy for gastric cancer in elderly patients
69. Evaluation of treatment strategies for gastric cancer in the elderly according to the number of abnormal parameters on preoperative examination
70. Less-invasive surgery for gastric cancer prolongs survival in patients over 80 years of age
71. Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of western and oriental trials
72. Adjuvant therapy for gastric carcinoma: Closing out the century
73. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia
74. Photodynamic therapy for oesophageal tumours
75. Intraluminal brachytherapy in the treatment of oesophageal cancers - Some preliminary results
76. Palliation of obstructing gastric carcinoma with metal stents through a gastrostomy
77. Percutaneous endoscopic duodenostomy: The relief of obstruction in advanced gastric carcinoma
78. Extrahepatic biliary obstruction by metastatic gastric carcinoma
79. The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma
80. Enteral or parenteral feeding after total gastrectomy; Prospective randomised pilot study
81. Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis
82. A case of combined gastrojejunal and gastrocolic fistula secondary to gastric cancer
83. A consideration in the care of elderly patients receiving home hospice care: Administration of parenteral nutrition at home
84. Home parenteral nutrition for terminal stage of cancer patient
85. Home care for terminally ill cancer patients in 1997
86. Our experience of home parenteral nutrition (HPN) for digestive disease patients
87. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer
88. Percutaneous endoscopic gastrostomy
89. Percutaneous endoscopic gastrostomy: A community hospital experience
90. Audit of percutaneous endoscopic gastrostomy in long-term enteral feeding in a nursing home
91. The use of percutaneous endoscopic gastrostomy (PEG) in 161 consecutive elderly patients
92. Tube feeding. Internists' attitudes regarding ethical obligations
93. Belgian doctors' attitudes on the management of patients in persistent vegetative state (PVS): Ethical and regulatory aspects
94. Surrogate decision-makers' satisfaction with the placement of feeding tubes in elderly patients
95. Tube feeding dilemmas: Can artificial nutrition and hydration be legally or ethically withheld or withdrawn?